OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials
Thomas Kofler, Reto Kurmann, Dirk Lehnick, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 16
Open Access | Times Cited: 45
Thomas Kofler, Reto Kurmann, Dirk Lehnick, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 16
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Metabolic dysfunction-associated steatotic liver disease and the heart
Stan Driessen, Sven Francque, Stefan D. Anker, et al.
Hepatology (2023)
Open Access | Times Cited: 32
Stan Driessen, Sven Francque, Stefan D. Anker, et al.
Hepatology (2023)
Open Access | Times Cited: 32
2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome.
Kwo‐Chang Ueng, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2023) Vol. 39, Iss. 1, pp. 4-96
Closed Access | Times Cited: 26
Kwo‐Chang Ueng, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2023) Vol. 39, Iss. 1, pp. 4-96
Closed Access | Times Cited: 26
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials
Aernoud T.L. Fiolet, Michiel H.F. Poorthuis, Tjerk S.J. Opstal, et al.
EClinicalMedicine (2024) Vol. 76, pp. 102835-102835
Open Access | Times Cited: 10
Aernoud T.L. Fiolet, Michiel H.F. Poorthuis, Tjerk S.J. Opstal, et al.
EClinicalMedicine (2024) Vol. 76, pp. 102835-102835
Open Access | Times Cited: 10
Colchicine in atherosclerotic cardiovascular disease
Bradley Tucker, N. Goonetilleke, Sanjay Patel, et al.
Heart (2024), pp. heartjnl-323177
Closed Access | Times Cited: 9
Bradley Tucker, N. Goonetilleke, Sanjay Patel, et al.
Heart (2024), pp. heartjnl-323177
Closed Access | Times Cited: 9
Update on the Role of Colchicine in Cardiovascular Disease
Darcy Banco, Mohammad Hashim Mustehsan, Binita Shah
Current Cardiology Reports (2024) Vol. 26, Iss. 4, pp. 191-198
Closed Access | Times Cited: 9
Darcy Banco, Mohammad Hashim Mustehsan, Binita Shah
Current Cardiology Reports (2024) Vol. 26, Iss. 4, pp. 191-198
Closed Access | Times Cited: 9
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomised control trials
Edward W. Webster, Adam Perkovic, Brendon L. Neuen, et al.
Clinical Kidney Journal (2025) Vol. 18, Iss. 3
Open Access | Times Cited: 1
Edward W. Webster, Adam Perkovic, Brendon L. Neuen, et al.
Clinical Kidney Journal (2025) Vol. 18, Iss. 3
Open Access | Times Cited: 1
Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin‐1
Marco Giuseppe Del Buono, Aldo Bonaventura, Alessandra Vecchié, et al.
European Journal of Clinical Investigation (2023) Vol. 54, Iss. 2
Closed Access | Times Cited: 22
Marco Giuseppe Del Buono, Aldo Bonaventura, Alessandra Vecchié, et al.
European Journal of Clinical Investigation (2023) Vol. 54, Iss. 2
Closed Access | Times Cited: 22
Inflammation in Cardiovascular Disease: A Comprehensive Review of Biomarkers and Therapeutic Targets
Lovish Gupta, Jingle Thomas, Rakshana Ravichandran, et al.
Cureus (2023)
Open Access | Times Cited: 17
Lovish Gupta, Jingle Thomas, Rakshana Ravichandran, et al.
Cureus (2023)
Open Access | Times Cited: 17
The impact of colchicine on patients with acute and chronic coronary artery disease
Mehdi Madanchi, Mabelle Young, Gregorio Tersalvi, et al.
European Journal of Internal Medicine (2024) Vol. 125, pp. 1-9
Closed Access | Times Cited: 8
Mehdi Madanchi, Mabelle Young, Gregorio Tersalvi, et al.
European Journal of Internal Medicine (2024) Vol. 125, pp. 1-9
Closed Access | Times Cited: 8
Frontiers and hotspots evolution in anti-inflammatory studies for coronary heart disease: A bibliometric analysis of 1990–2022
Jiale Zhang, Chenyang Ji, Xu Zhai, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Jiale Zhang, Chenyang Ji, Xu Zhai, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Colchicine and plaque: A focus on atherosclerosis imaging
Jairo Aldana-Bitar, Ilana Golub, Jeffrey E. Moore, et al.
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 5
Jairo Aldana-Bitar, Ilana Golub, Jeffrey E. Moore, et al.
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 5
Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: emulation of target trials
Patrick Heindel, James J Fitzgibbon, Eric A. Secemsky, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 5
Patrick Heindel, James J Fitzgibbon, Eric A. Secemsky, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 5
The Role of Colchicine in Atherosclerosis: From Bench to Bedside
Leticia González, Juan Francisco Bulnes, María Paz Orellana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1395-1395
Open Access | Times Cited: 19
Leticia González, Juan Francisco Bulnes, María Paz Orellana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1395-1395
Open Access | Times Cited: 19
Colchicin – Phönix aus der Asche
Raimund Lunzer, Georg Delle‐Karth, Markus Zeitlinger, et al.
Wiener klinische Wochenschrift (2025) Vol. 137, Iss. S1, pp. 1-33
Open Access
Raimund Lunzer, Georg Delle‐Karth, Markus Zeitlinger, et al.
Wiener klinische Wochenschrift (2025) Vol. 137, Iss. S1, pp. 1-33
Open Access
Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials
Zijun Ma, Jun Chen, Kaiqin Jin, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 15
Zijun Ma, Jun Chen, Kaiqin Jin, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 15
Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure
Mary E. Roth, Melissa E. Chinn, Steven P. Dunn, et al.
Clinical Cardiology (2022) Vol. 45, Iss. 7, pp. 733-741
Open Access | Times Cited: 13
Mary E. Roth, Melissa E. Chinn, Steven P. Dunn, et al.
Clinical Cardiology (2022) Vol. 45, Iss. 7, pp. 733-741
Open Access | Times Cited: 13
Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia
Gary F. Lewis, Robert A. Hegele
The Lancet Diabetes & Endocrinology (2021) Vol. 10, Iss. 2, pp. 142-148
Closed Access | Times Cited: 16
Gary F. Lewis, Robert A. Hegele
The Lancet Diabetes & Endocrinology (2021) Vol. 10, Iss. 2, pp. 142-148
Closed Access | Times Cited: 16
Importance of Intermittent Fasting Regimens and Selection of Adequate Therapy on Inflammation and Oxidative Stress in SARS-CoV-2 Infection
Armin Ezzati, Sara K. Rosenkranz, Benjamin D. Horne
Nutrients (2022) Vol. 14, Iss. 20, pp. 4299-4299
Open Access | Times Cited: 11
Armin Ezzati, Sara K. Rosenkranz, Benjamin D. Horne
Nutrients (2022) Vol. 14, Iss. 20, pp. 4299-4299
Open Access | Times Cited: 11
Targeting Inflammation in the Diagnosis, Management, and Prevention of Cardiovascular Diseases
Akira Matsumori
Global Heart (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Akira Matsumori
Global Heart (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Select drug-drug interactions with colchicine and cardiovascular medications: A review
Dave L. Dixon, Jaideep Patel, Rowan Spence, et al.
American Heart Journal (2022) Vol. 252, pp. 42-50
Closed Access | Times Cited: 9
Dave L. Dixon, Jaideep Patel, Rowan Spence, et al.
American Heart Journal (2022) Vol. 252, pp. 42-50
Closed Access | Times Cited: 9
Colchicine enhances β adrenoceptor‐mediated vasodilation in men with essential hypertension
Thomas S. Ehlers, Jennifer van der Horst, Sophie Møller, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 7, pp. 2179-2189
Open Access | Times Cited: 5
Thomas S. Ehlers, Jennifer van der Horst, Sophie Møller, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 7, pp. 2179-2189
Open Access | Times Cited: 5
Inflammation, anti-inflammatory agents, and the role of colchicine in carotid artery stenosis
David‐Dimitris Chlorogiannis, Sumant Pargaonkar, Panagiotis Papanagiotou, et al.
VASA (2023) Vol. 53, Iss. 1, pp. 4-12
Closed Access | Times Cited: 4
David‐Dimitris Chlorogiannis, Sumant Pargaonkar, Panagiotis Papanagiotou, et al.
VASA (2023) Vol. 53, Iss. 1, pp. 4-12
Closed Access | Times Cited: 4
Immunotherapeutic Strategies in Cancer and Atherosclerosis—Two Sides of the Same Coin
Felix Sebastian Nettersheim, Felix S.R. Picard, Friedrich Felix Hoyer, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 7
Felix Sebastian Nettersheim, Felix S.R. Picard, Friedrich Felix Hoyer, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 7
Effects of colchicine use on ischemic and hemorrhagic stroke risk in diabetic patients with and without gout
Jun‐Jun Yeh, I‐Ling Kuo, Hei‐Tung Yip, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Jun‐Jun Yeh, I‐Ling Kuo, Hei‐Tung Yip, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
A cloud-based medical device for predicting cardiac risk in suspected coronary artery disease: a rapid review and conceptual economic model
Marie Westwood, Nigel Armstrong, Eline Krijkamp, et al.
Health Technology Assessment (2024), pp. 1-105
Open Access | Times Cited: 1
Marie Westwood, Nigel Armstrong, Eline Krijkamp, et al.
Health Technology Assessment (2024), pp. 1-105
Open Access | Times Cited: 1
